How Has the COVID-19 Pandemic Affected Blood Transfusion Supply, Use?
Due to the COVID-19 pandemic, patterns of blood transfusion demands are not certain; therefore, institutions should plan for a reduction in donations.
Hematology
PRIME Cells Identified in Blood Before Flare in Rheumatoid Arthritis
Distinct RNA signatures are evident in peripheral blood of rheumatoid arthritis patients before a disease flare.
Thrombosis and Iron Deficient Anemia: Determining Trends in Thrombotic Complications
Although the association between thrombocytosis in iron deficiency anemia is understood, researchers studied the risk for thrombotic complications.
Clotting and COVID: New Guidelines in the Works to Treat Coagulopathies in Patients With COVID-19
Growing concerns about thromboembolic comorbidities in patients with COVID-19 is leading ASH to create clinical practice guidelines to treat this patient population.
Close Monitoring, Full-Time Caregiver Recommended for 30 Days After CAR-T Therapy
Readmissions for CRS, neurotoxicity, infection, and other adverse events are common after immunotherapy with axicabtagene ciloleucel.
Thromboelastography Can Predict Blood Clots in COVID-19
Hypercoagulable thromboelastography can predict thrombotic events in patients with COVID-19 in the intensive care unit.
Early Data Show Potential Benefit of Acalabrutinib in Severe COVID-19
Acalabrutinib, a Bruton tyrosine kinase (BTK) inhibitor, appears to reduce respiratory distress as well as the hyperinflammatory immune response associated with coronavirus disease 2019.
Combination Phototherapy Beneficial for Reducing Total Serum Bilirubin Levels in Infants
Researchers compared 4 phototherapy methods and evaluated phototherapy duration and decline to reduce total serum bilirubin levels in infants.
Post-Traumatic Stress Symptoms After Hematopoietic Stem Cell Transplantation
Six months after hematopoietic stem cell transplantation, nearly 20% of enrolled patients had experienced clinically significant PTSD symptoms.
FDA Approval Expands Access of Artesunate for Malaria Treatment
The FDA has approved Artesunate for Injection (Amivas) for the initial treatment of severe malaria in adult and pediatric patients.
-
Loading...
-
Loading...
Next post in Hematology Information Center
